WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Aspyra, Inc. (AMEX: APY), a provider of clinical and diagnostic information systems for the healthcare industry, today reported it has received notice from NYSE Amex LLC (the “Exchange”) that the Company does not meet one of the Exchange’s continued listing standards as set forth in Part 10 of the NYSE Amex LLC Company Guide (the “Company Guide”). The notice reports that Aspyra is not in compliance with Section 1003(a)(iv)
For more information, please visit
http://www.businesswire.com/news/home/20090930006416/en